Chlorhexidine gluconate-impregnated central-line dressings and necrosis in complicated skin disorder patients

Journal of Critical Care

Volumn 29, Issue 6, 2014, Pages 1130.e1-1130.e4

  Wall, Jennifer B ^a   Divito, Sherrie J ^a   Talbot, Simon G ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Burn; Central line associated blood stream infections (CLABSIs); Chlorhexidine gluconate (CHG) disk; Graft vs host disease (GvHD); Stevens Johnson syndrome (SJS); Toxic epidermal necrolysis (TENS)

Indexed keywords

CHLORHEXIDINE GLUCONATE; CHLORHEXIDINE; TOPICAL ANTIINFECTIVE AGENT;

ADULT; AGED; ANASARCA; APPLICATION SITE BURNING; ARTICLE; BACTERIUM IDENTIFICATION; BURN; CANDIDA PARAPSILOSIS; CENTRAL VENOUS CATHETERIZATION; CHLORHEXIDINE GLUCONATE DISK; CLINICAL ARTICLE; CRITICALLY ILL PATIENT; DEVICE REMOVAL; DEVICE THERAPY; DISEASE PREDISPOSITION; ENTEROCOCCUS FAECIUM; EPITHELIZATION; FEMALE; GRAFT VERSUS HOST REACTION; HUMAN; MALE; MEDICAL DEVICE COMPLICATION; MIDDLE AGED; RISK ASSESSMENT; SKIN NECROSIS; STEVENS JOHNSON SYNDROME; TOXIC EPIDERMAL NECROLYSIS; TREATMENT RESPONSE; VERY ELDERLY; WOUND DRESSING; WOUND HEALING; YOUNG ADULT; ANALOGS AND DERIVATIVES; BANDAGE; CASE REPORT; CATHETER-RELATED INFECTIONS; CRITICAL ILLNESS; FATALITY; STEVENS-JOHNSON SYNDROME;

ADULT; AGED; AGED, 80 AND OVER; ANTI-INFECTIVE AGENTS, LOCAL; BANDAGES; CATHETER-RELATED INFECTIONS; CHLORHEXIDINE; CRITICAL ILLNESS; FATAL OUTCOME; FEMALE; HUMANS; MALE; MIDDLE AGED; STEVENS-JOHNSON SYNDROME; YOUNG ADULT;

EID: 84908121528     PISSN: 08839441     EISSN: 15578615     Source Type: Journal    
DOI: 10.1016/j.jcrc.2014.06.001     Document Type: Article

References (16)

1. Ho K.M., Litton E. Use of chlorhexidine-impregnated dressing to prevent vascular and epidural catheter colonization and infection: a meta-analysis. J Antimicrob Chemother 2006, 58(2):281-287.
2. Timsit J.F., Mimoz O., Mourvillier B., Souweine B., Garrouste-Orgeas M., Alfandari S., et al. Randomized controlled trial of chlorhexidine dressing and highly adhesive dressing for preventing catheter-related infections in critically ill adults. Am J Respir Crit Care Med 2012, 186(12):1272-1278.
3. Garland J.S., Alex C.P., Mueller C.D., Cisler-Kahill L.A. Local reactions to a chlorhexidine gluconate-impregnated antimicrobial dressing in very low birth weight infants. Pediatr Infect Dis J 1996, 15(10):912-914.
4. Garland J.S., Alex C.P., Mueller C.D., Otten D., Shivpuri C., Harris M.C., et al. A randomized trial comparing povidone-iodine to a chlorhexidine gluconate-impregnated dressing for prevention of central venous catheter infections in neonates. Pediatrics 2001, 107(6):1431-1436.
5. Garland J.S., Alex C.P., Uhing M.R., Peterside I.E., Rentz A., Harris M.C. Pilot trial to compare tolerance of chlorhexidine gluconate to povidone-iodine antisepsis for central venous catheter placement in neonates. J Perinatol 2009, 29(12):808-813.
6. Garland J.S., Buck R.K., Maloney P., Durkin D.M., Toth-Lloyd S., Duffy M., et al. Comparison of 10% povidone-iodine and 0.5% chlorhexidine gluconate for the prevention of peripheral intravenous catheter colonization in neonates: a prospective trial. Pediatr Infect Dis J 1995, 14(6):510-516.
7. Lissia M., Mulas P., Bulla A., Rubino C. Toxic epidermal necrolysis (Lyell's disease). Burns 2010, 36(2):152-163.
8. Hymes S.R., Alousi A.M., Cowen E.W. Graft-versus-host disease: part II. Management of cutaneous graft-versus-host disease. J Am Acad Dermatol 2012, 66(4):535.e1-535.e16. [quiz 551-2].
9. Hymes S.R., Alousi A.M., Cowen E.W. Graft-versus-host disease: part I. Pathogenesis and clinical manifestations of graft-versus-host disease. J Am Acad Dermatol 2012, 66(4):515.e1-515.e18. [quiz 533-4].
10. Zhai H., Meier-Davis S.R., Cayme B., Shudo J., Maibach H. Irritant contact dermatitis: effect of age. Cutan Ocul Toxicol 2012, 31(2):138-143.
11. Harpin V., Rutter N. Percutaneous alcohol absorption and skin necrosis in a preterm infant. Arch Dis Child 1982, 57(6):477-479.
12. Harpin V.A., Rutter N. Barrier properties of the newborn infant's skin. J Pediatr 1983, 102(3):419-425.
13. Weitz N.A., Lauren C.T., Weiser J.A., LeBoeuf N.R., Grossman M.E., Biagas K. Chlorhexidine gluconate-impregnated central access catheter dressings as a cause of erosive contact dermatitis: a report of 7 cases. JAMA Dermatol 2013, 149(2):195-199.
14. Chapman A.K., Aucott S.W., Gilmore M.M., Advani S., Clarke W., Milstone A.M. Absorption and tolerability of aqueous chlorhexidine gluconate used for skin antisepsis prior to catheter insertion in preterm neonates. J Perinatol 2013, 33(10):768-771.
15. Chapman A.K., Aucott S.W., Milstone A.M. Safety of chlorhexidine gluconate used for skin antisepsis in the preterm infant. J Perinatol 2012, 32(1):4-9.
16. Ale S.I., Maibach H.I. Reproducibility of patch test results: a concurrent right-versus-left study using TRUE Test. Contact Dermatitis 2004, 50(5):304-312.